The Hatch Podcast · 2026-06-04 · 12 min
What if researchers could test new medicines on lab-grown human tissue before they ever reached clinical trials? In this episode of our Building Biotech in Lower Alabama series, Stephanie Glines sits down with Yuan Tian, founder of Vivosphere, to discuss how his company is developing artificial human tissue models designed to improve drug discovery and regenerative medicine. Yuan shares his journey from arriving in the United States with two suitcases to earning a Ph.D. at Auburn University and transforming his research into a biotech startup. He explains how Vivosphere’s technology creates 3D human tissue models that mimic how cells behave inside the body, helping researchers evaluate potential therapies more accurately before they reach patients. The conversation explores the challenges of drug development, the potential of regenerative medicine, the role of artificial intelligence in biotech, and how the Hatch Biotech Accelerator helped prepare Vivosphere for future growth.
Turning Personal Pain Into Innovation: Hannah Keel & Brayden Gibson on Southern Rooted | Building Biotech40 / 100AI Accelerating Medical Innovation: Vipul Kashyap on Medhive.ai | Building BiotechBuilding a Safer Future for Medical Device Sterilization: Michelle Scott on Gulf Sterilization | Building BiotechFrom Air Force Research to a Medical Breakthrough: David Nelson on Spectratherm | Building BiotechTurning Mental Health Awareness Into Action: Marlo Young on Mentalocity | Building Biotech